This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
Core Strategy of Research and Development
Astellas sets targets of research and development (R&D) from multiple perspectives through the Focus Area approach and works to create innovative medicines to fulfill high unmet medical needs based on the concepts of Best Science, Best Talent (optimal personnel), and Best Place (optimum environment).
We determine the priorities of development candidates at the early stages and optimize resource allocation according to priorities. These efforts have achieved results in reduction of the time for R&D and improvement of cost efficiency.
In late-stage development, we allocate management resources extensively to six key post-POC* projects. We aim to characterize the therapeutic potential of these projects in development.